ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹137 Cr | ₹2.46 Cr | ₹167 Cr | ₹31 Cr | ₹-217 Cr |
What is the latest Cash Flow from Financing Activities ratio of ORCHID PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹137 Cr |
| Mar2025 | ₹2.46 Cr |
| Mar2024 | ₹167 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹-217 Cr |
How is Cash Flow from Financing Activities of ORCHID PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹137 Cr | 5,481.52 | |
| Mar2025 | ₹2.46 Cr | -98.53 | |
| Mar2024 | ₹167 Cr | 435.97 | |
| Mar2023 | ₹31 Cr | Positive | |
| Mar2022 | ₹-217 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹6,610.9 Cr | 15.4% | 6.3% | 55.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 15.4% |
6.3% |
55.3% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses